ilmscore | 5 Stocks to Buy Booming from Bad to Best

5 Stocks to Buy Booming from Bad to Best

Published: 2025-04-16
Status: Analyzed

Predictions from this Video

Total: 6
Correct: 0
Incorrect: 0
Pending: 6
Prediction
Topic
Status
Humana stock is predicted to reach $400 per share, representing a 56% increase from the current price.
"The stock could be worth $400 per share or 56% higher than the current price."
HUM
Pending
Dollar General stock is predicted to reach $117 per share, offering a 35% upside, based on a return to its average price-to-sales multiple.
"Shares are still relatively cheap here at46 time sales and a bounce back to that average of6 times multiple would mean a $117 share price and a 35% upside."
DG
Pending
UBS analysts predict Nucor stock to reach $160 per share.
"UBS rating the stock for a buy and $160 price target."
NUE
Pending
Nucor stock is predicted to be worth $149 per share, representing a 44% upside, based on a 1.15x price-to-sales valuation multiple.
"On forecasted sales and back up to 1.15 times valuation, the stock could be worth $149 a share or 44% upside."
NUE
Pending
In 2022, the author predicted that Intel's strategy of trying to design and fabricate semiconductors would ruin the company.
"Something I pointed to in 2022 would ruin the company already struggling just to design chips."
INTC
Pending
CVS Health stock is predicted to reach $93 per share, offering a 38% upside, based on a return to a 0.3x price-to-sales valuation.
"But on forecasted sales of 390 billion, a return to.3 times on that price to sales valuation could bring a $93 share price target or a 38% upside from here."
CVS
Pending